San Diego, CA, United States of America

Brett Skolnick

This inventor holds 1 USPTO granted patent. Top assignee: Receptos, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brett Skolnick. Retrieved from https://idiyas.com/inventor/brett-skolnick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brett Skolnick: Innovator in Neuroprotection

Introduction

Brett Skolnick is a notable inventor based in San Diego, California. He has made significant contributions to the field of neuroprotection through his innovative research and development.

Latest Patents

Brett Skolnick holds a patent for "Sphingosine 1 phosphate receptor agonists for neuroprotection." This patent outlines methods for treating conditions where S1P-mediated neuroprotection is medically indicated. The invention involves administering an agonist of the sphingosine 1-phosphate receptor to a subject in need, which may include a compound with a specific structure or its pharmaceutically acceptable variants.

Career Highlights

Brett Skolnick has established himself as a key figure in the pharmaceutical industry, particularly through his work at Receptos, Inc. His research focuses on developing therapies that leverage the sphingosine 1-phosphate receptor for neuroprotective applications.

Collaborations

Throughout his career, Brett has collaborated with several professionals, including Kristen R Taylor Meadows and Deepak Dalvie. These collaborations have contributed to the advancement of his research and the development of innovative treatments.

Conclusion

Brett Skolnick's work in neuroprotection exemplifies the impact of innovative thinking in medicine. His contributions continue to pave the way for new therapeutic approaches in treating neurological conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…